![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Huber, Rudolf M.; Hansen, Karin H.; Paz-Ares Rodriguez, Luis; West, Howard L.; Reckamp, Karen L.; Leighl, Natasha B.; Tiseo, Marcello; Smit, Egbert F.; Kim, Dong-Wan; Gettinger, Scott N.; Hochmair, Maximilian J.; Kim, Sang-We; Langer, Corey J.; Ahn, Myung-Ju; Kim, Edward S.; Kerstein, David; Groen, Harry J. M. und Camidge, D. Ross
(2020):
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial.
In: Journal of Thoracic Oncology, Bd. 15, Nr. 3: S. 404-415
Camidge, D. Ross; Kim, Dong-Wan; Tiseo, Marcello; Langer, Corey J.; Ahn, Myung-Ju; Shaw, Alice T.; Huber, Rudolf M.; Hochmair, Maximilian J.; Lee, Dae Ho; Bazhenova, Lyudmila A.; Gold, Kathryn A.; Ou, Sai-Hong Ignatius; West, Howard L.; Reichmann, William; Haney, Jeff; Clackson, Tim; Kerstein, David und Gettinger, Scott N.
(2018):
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.
In: Journal of Clinical Oncology, Bd. 36, Nr. 26: S. 2693-2701
Kim, Dong-Wan; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen L.; Hansen, Karin Holmskov; Kim, Sang-We; Huber, Rudolf M.; West, Howard L.; Grön, Harry J. M.; Hochmair, Maximilian J.; Leighl, Natasha B.; Gettinger, Scott N.; Langer, Corey J.; Rodriguez, Luis G. Paz-Ares; Smit, Egbert F.; Kim, Edward S.; Reichmann, William; Haluska, Frank G.; Kerstein, David und Camidge, D. Ross
(2017):
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
In: Journal of Clinical Oncology, Bd. 35, Nr. 22: S. 2490-2500
Camidge, D. Ross; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen; Hansen, Karin; Kim, Sang-We; Huber, Rudolf; West, Howard; Grön, Harry; Hochmair, Maximilian; Leighl, Natasha; Gettinger, Scott; Langer, Corey; Paz-Ares, Luis; Smit, Egbert; Kim, Edward; Reichmann, William; Clackson, Tim; Kerstein, David; Haluska, Frank und Kim, Dong-Wan
(2017):
Brigatinib in Crizotinib-Refractory ALK plus NSCLC: Central Assessment and Updates from ALTA, a Pivotal Randomized Phase 2 Trial.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S1167-S1169
Gettinger, Scott; Kim, Dong-Wan; Tiseo, Marcello; Langer, Corey; Ahn, Myung-Ju; Shaw, Alice; Huber, Rudolf; Hochmair, Maximilian; Kim, Sang-We; Bazhenova, Lyudmila; Gold, Kathryn; Ou, Sai-Hong; West, Howard; Reichmann, William; Haney, Jeff; Clackson, Tim; Haluska, Frank; Kerstein, David und Camidge, D. Ross
(2017):
Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S273-S274
Ardizzoni, Andrea; Tiseo, Marcello; Boni, Luca; Di Maio, Massimo; Buffoni, Lucio; Belvedere, Ornella; Grossi, Francesco; D'Alessandro, Vito; De Marinis, Filippo; Barbera, Santi; Caroti, Cinzia; Favaretto, Adolfo; Cortinovis, Diego; Monica, Brunello; Tixi, Lucia; Ceschia, Tino; Parisi, Salvatore; Ricardi, Umberto; Grimaldi, Andrea; Loreggian, Lucio; Navarriat, Pierina; Huber, Rudolf M.; Belani, Chandra; Bruswig, Paal Fr.; Scagliotti, Giorgio Vittorio und Scolaro, Tindaro
(2016):
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.
In: Lung Cancer, Bd. 100: S. 30-37